Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/a-1802-0220
Anti-reflux mucosectomy for refractory gastroesophageal reflux disease: a systematic review and meta-analysis[*]
![](https://www.thieme-connect.de/media/10.1055-s-00025476/202206/lookinside/thumbnails/2519_10-1055-a-1802-0220-1.jpg)
Abstract
Background and study aims Anti-reflux mucosectomy (ARMS) is an emerging endoscopic treatment for refractory gastroesophageal reflux disease (GERD). We conducted a systematic review and meta-analysis to evaluate the safety and efficacy ARMS in refractory GERD.
Methods A comprehensive search of multiple databases (through March 2020) was performed to identify studies that reported outcomes of ARMS for refractory GERD. Outcomes assessed included technical success, clinical response, and adverse events (AEs). Clinical response was defined as discontinuation (complete) or reduction (partial) of proton pump inhibitors post-ARMS at follow up.
Results A total of 307 patients (mean age 46.9 [8.1] years, 41.5 % females) were included from 10 studies. The technical success and clinical response rates were 97.7 % (95 % confidence interval [CI], 94.6–99.0) and 80.1 % (95 % CI, 61.6–91.0), respectively. The pooled rate of complete and partial clinical response was 65.3 % (95 % CI, 51.4–77.0) and 21.5 % (95 % CI, 14.2–31.2), respectively. The rate of AEs was 17.2 % (95 % CI, 13.1–22.2) with most common AE being dysphagia/esophageal stricture followed by bleeding with rates of 11.4 % and 5.0 %, respectively. GERD health-related quality of life (GERD-HRQL) (mean difference [MD] = 14.9, P < 0.001), GERD questionnaire (GERD-Q) (MD = 4.85, P < 0.001) and mean acid exposure time (MD = 2.39, P = 0.01) decreased significantly post-ARMS as compared to pre-procedure. There was no difference in terms of clinical response and AEs between ARMS and ARMS with banding on subgroup analysis.
Conclusions ARMS is a safe and effective procedure for treatment of refractory GERD with high rates of clinical response, acceptable safety profile and significant improvement in GERD-related quality of life. Prospective studies are needed to validate our findings.
* Meeting presentations: An abstract of this manuscript was accepted for poster presentation at the American College of Gastroenterology, 2021.
Publication History
Received: 23 August 2021
Accepted after revision: 15 November 2021
Article published online:
10 June 2022
© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Dent J, El-Serag HB, Wallander MA. et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 710-717
- 2 Miner Jr. P, Katz PO, Chen Y. et al. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol 2003; 98: 2616-2620
- 3 Subramanian CR, Triadafilopoulos G. Refractory gastroesophageal reflux disease. Gastroenterol Rep 2015; 3: 41-53
- 4 Oelschlager BK, Quiroga E, Parra JD. et al. Long-term outcomes after laparoscopic antireflux surgery. Am J Gastroenterol 2008; 103: 280-287 quiz 288
- 5 Dominitz JA, Dire CA, Billingsley KG. et al. Complications and antireflux medication use after antireflux surgery. Clin Gastroenterol Hepatol 2006; 4: 299-305
- 6 Ganz RA, Peters JH, Horgan S. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med 2013; 368: 2039-2040
- 7 Sanmiguel CP, Hagiike M, Mintchev MP. et al. Effect of electrical stimulation of the LES on LES pressure in a canine model. Am J Physiol Gastrointest Liver Physiol 2008; 295: G389-G394
- 8 Bonavina L, Saino G, Bona D. et al. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center. J Am Coll Surg 2013; 217: 577-585
- 9 Falk GW, Fennerty MB, Rothstein RI. AGA Institute technical review on the use of endoscopic therapy for gastroesophageal reflux disease. Gastroenterol 2006; 131: 1315-1336
- 10 Inoue H, Ito H, Ikeda H. et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol 2014; 27: 346-351
- 11 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: The prisma statement. Ann Int Med 2009; 151: 264-269
- 12 Stroup DF, Berlin JA, Morton SC. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012
- 13 Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Europ J Epidemiol 2010; 25: 603-605
- 14 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7: 177-188
- 15 Sutton AJ, Abrams KR, Jones DR. et al. Methods for meta-analysis in medical research. John Wiley & Sons Ltd New York 2000; 2000: 205-228
- 16 Higgins JP, Thompson SG, Deeks JJ. et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557
- 17 Guyatt GH, Oxman AD, Kunz R. et al. GRADE guidelines: 7. Rating the quality of evidence & inconsistency. J Clin Epidemiol 2014; 64: 1294-1302
- 18 Easterbrook PJ, Gopalan R, Berlin JA. et al. Publication bias in clinical research. Lancet 1991; 337: 867-872
- 19 Bapaye A, Mahadik M, Pujari R. et al. Anti-reflux mucosectomy (ARMS) for refractory GERD-Initial clinical experience. J Gastroenterol Hepatol 2017; 32: 255
- 20 Debourdeau A, Vitton V, Monino L. et al. Antireflux Mucosectomy Band (ARM-b) in treatment of refractory gastroesophageal reflux disease after bariatric surgery. Obesity Surg 2020; 30: 4654-4658
- 21 Kessler WR, McNulty G, Lehman GA. A prospective, randomized study on the effect of band ligation with or without mucosectomy as a treatment for GERD: Pilot study, 12 month experience. Gastrointest Endosc 2013; 77: AB120
- 22 Mohan Prasad VG, Appadurai S, Suman MP. Anti-reflux mucosectomy (ARMS) for refractory GERD-Our 3yrs experience. J Gastroenterol Hepatol 2019; 34: 232
- 23 Monino L, Gonzalez JM, Vitton V. et al. Antireflux mucosectomy band in treatment of refractory gastroesophageal reflux disease: a pilot study for safety, feasibility and symptom control. Endosc Int Open 2020; 8: E147-E154
- 24 Ortega A, Roson P, Fernandez F. et al. Antireflux mucosectomy. preliminary results of a prospective study. Endoscopy 2019; 51: S240-S241
- 25 Patil G, Dalal A, Maydeo A. Feasibility and outcomes of anti-reflux mucosectomy for proton pump inhibitor dependent gastroesophageal reflux disease: First Indian study (with video). Digest Endosc 2020; 32: 745-752
- 26 Sumi K, Inoue H, Kobayashi Y. et al. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases. Dig Endosc 2021; 33: 347-354
- 27 Wong HJ, Su B, Attaar M. et al. Anti-reflux mucosectomy (ARMS) results in improved recovery and similar reflux quality of life outcomes compared to laparoscopic Nissen fundoplication. Surg Endosc Other Intervent Tech 2021; DOI: 10.1007/s00464-020-08144-9.
- 28 Yoo I, Ko WJ, Kim HS. et al. Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study. Surg Endosc 2020; 34: 1124-1131
- 29 Mohan BP, Adler DG. Heterogeneity in systematic review and meta-analysis: how to read between the numbers. Gastrointest Endosc 2019; 89: 902-903
- 30 Velanovich V, Vallance SR, Gusz JR. et al. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 1996; 183: 217-224
- 31 Jones R, Junghard O, Dent J. et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 2009; 30: 1030-1038
- 32 Jamieson JR, Stein HJ, DeMeester TR. et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992; 87: 1102-1111
- 33 Johnson LF, DeMeester TR. Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol 1986; 8: 52-58
- 34 Shimamura Y, Inoue H. Anti-reflux mucosectomy: Can we do better?. Dig Endosc 2020; 32: 736-738
- 35 Lipham JC, DeMeester TR, Ganz RA. et al. The LINX(R) reflux management system: confirmed safety and efficacy now at 4 years. Surg Endosc 2012; 26: 2944-2949
- 36 Rodriguez L, Rodriguez P, Gomez B. et al. Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: final results of open-label prospective trial. Surg Endosc 2013; 27: 1083-1092
- 37 Triadafilopoulos G. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease. World J Gastroenterol 2014; 20: 7730-7738
- 38 Danalioglu A, Cipe G, Toydemir T. et al. Endoscopic stapling in comparison to laparoscopic fundoplication for the treatment of gastroesophageal reflux disease. Dig Endosc 2014; 26: 37-42
- 39 Richter JE, Kumar A, Lipka S. et al. Efficacy of laparoscopic Nissen fundoplication vs transoral incisionless fundoplication or proton pump inhibitors in patients with gastroesophageal reflux disease: a systematic review and network meta-analysis. Gastroenterology 2018; 154: 1298-1308 e1297
- 40 McCarty TR, Itidiare M, Njei B. et al. Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis. Endoscopy 2018; 50: 708-725
- 41 Dodds WJ, Dent J, Hogan WJ. et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982; 307: 1547-1552
- 42 Tanabe M, Inoue H, Ueno A. et al. Sa1255 A novel endoscopic fundoplication for gastroesophageal reflux disease; anti-reflux mucosal ablation (ARMA). Gastrointest Endosc 2019; 89: AB190